Physician profile
Eric Munoz
NPI 1982607529
$6,267.11
in general payments reported to CMS, 2019-2025
12 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,959 · 2020: $218 · 2021: $115 · 2022: $959 · 2023: $422 · 2024: $340 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,016.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,905.18 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Inspiris Resilia Aortic Valve |
| Abiomed | $574.02 | 2022-2025 | |
| Medtronic, INC. | $284.12 | 2021-2024 | Corevalve Evolut R |
| Abbott Laboratories | $276.67 | 2023-2025 | Epic, Navitor, Mitraclip |
| Ethicon US, LLC | $79.28 | 2025 | Evarrest, Dermabond Prineo, Vistaseal |
| Lsi Solutions INC | $32.42 | 2025 | Cor-Knot |
| Lemaitre Vascular, INC. | $28.99 | 2025 | Cardiocel |
| Baxter Healthcare | $24.04 | 2022 | |
| Zimmer Biomet Holdings, INC. | $16.87 | 2023 | Sternalock Blu System |
| Astrazeneca Pharmaceuticals Lp | $16.46 | 2023 | Brilinta |
| Chiesi USA, INC. | $15.53 | 2023 | Cleviprex, Kengreal |
| Pfizer INC. | $13.53 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Munoz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.